New normal declared and staffed: management says the company's recent level of business has become its new baseline, and
The model's full reasoning — Q2 2017 call → NO我们根据提供的财报电话会议记录来判断。管理层是否将当前业务水平描述为新的常态,并且正在为此运营。 关键点:管理层提到“record revenues of $3.1 billion”,MS业务增长,SPINRAZA上市进展,生物类似药业务增长,以及战略更新。他们提到“we are increasingly focused on execution, maximizing the potential of both our commercial business and our pipeline and building new growth drivers for the future.” 他们提高了2017年收入指引。他们谈论了“inflection point for Biogen in the early 2020s”和“multiple-high assets”。他们提到“we aim to demonstrate that we can advance a broader world-class neuroscience pipeline”。 但问题具体问的是:管理层是否传达出当前业务水平已成为新的常态,即最近异常的活动现在被描述为公司的当前运营水平,并且管理层正在描述当前的工作以维持这一更高水平。 在电话会议中,管理层谈论了MS业务的增长,SPINRAZA的推出,生物类似药的增长,以及他们正在进行的战略举措。他们提到“We had a great first half of the year and we are excited to build on this momentum for the rest of 2017 and beyond.” 他们提高了收入指引。他们谈论了“record revenues”和“highest quarterly growth in over two years”。他们谈论了SPINRAZA的“significant uptake”和“strong demand”。他们谈论了生物类似药“revenues grew 37%”。 然而,他们是否明确表示这些水平是新的常态?他们谈论了“we are increasingly focused on execution”和“building new growth drivers”。他们谈论了“we aim to maximize the resilience of our MS core business”和“accelerating our efforts in spinal muscular atrophy”。他们谈论了“we are actively reallocating resources to high-priority R&D BD and commercial growth opportunities”。 但问题要求的是:管理层是否将当前活动水平描述为高于公司近期常态,并且将其视为当前运营水平,而不是一次性事件。在电话会议中,管理层没有明确说“这现在是我们的新常态”或类似的话。他们谈论了增长和势头,但并没有明确将当前水平与过去进行比较并说这是新的基线。他们确实提到了“record revenues”和“highest quarterly growth in over two years”,这暗示了高于近期水平,但他们没有明确说这是新的常态。他们谈论了未来的增长和战略,但并没有明确说当前水平是可持续的常态。 此外,他们提到了SPINRAZA的推出,但指出“we expect slower uptake in Type 2 patients through the balance of the year”由于脊柱手术的挑战,这表明他们预期增长会放缓。他们谈论了“we are working closely with physicians to understand best practices”等。 他们谈论了“we are now building on this momentum outside the U.S.”,但并没有明确说当前水平是新的常态。 在战略部分,他们谈论了“we see an inflection point for Biogen in the early 2020s”,这暗示未来会有更大的增长,但当前水平可能不是新的常态。 因此,我认为管理层没有明确传达当前业务水平已成为新的常态。他们谈论了增长和势头,但并没有明确说这是新的基线。他们也没有明确描述当前的工作以维持这一更高水平,尽管他们谈论了投资和资源分配。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ECPG | Encore Capital Group, Inc. | Q1 2024 | 2024-05-08 | B |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| PDS | Precision Drilling Corporation | Q1 2024 | 2024-04-25 | B |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| AEP | American Electric Power Company, Inc. | Q3 2023 | 2023-11-02 | C+ |
| GRBK | Green Brick Partners, Inc. | Q3 2023 | 2023-11-01 | B |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| TGT | Target Corporation | Q4 2022 | 2023-02-28 | C |
| UAL | United Airlines Holdings, Inc. | Q4 2022 | 2023-01-18 | B |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| EXFY | Expensify, Inc. | Q2 2022 | 2022-08-12 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| CME | CME Group Inc. | Q2 2022 | 2022-07-27 | B |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| HLIO | Helios Technologies, Inc. | Q1 2022 | 2022-05-10 | C |
| CCRN | Cross Country Healthcare, Inc. | Q1 2022 | 2022-05-04 | B |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| EVBN | Evans Bancorp, Inc. | Q4 2016 | 2017-02-06 | B+ |
UAL · Q4 2022 → YESThe question is: Does management convey that the LEVEL OF BUSINESS THE COMPANY IS NOW DOING HAS BECOME ITS NEW NORMAL — that activity which would recently have been exceptional is now the company's cu...YES The transcript shows management framing the post-pandemic operating environment—higher margins, sustained demand recovery, capacity constraints, and investments in staffing/technology—as the new baseline for United's business. Scott Kirby explicitly states that structural changes have set the industry (and United) up for higher margins than pre-pandemic levels, with United achieving 9% adjusted pre-tax margin in H2 2022 ahead of schedule and expecting to hit it again in 2023. They describe current activity (e.g.
CRL · Q2 2022 → YESThe question is whether management conveys that the current level of business has become the new normal, meaning activity that would recently have been exceptional is now ordinary, and they're doing r...YES The transcript shows management framing the elevated activity in Safety Assessment (DSA segment) as the new baseline: backlog "well above the prior year level," "significantly above prior year levels," "unprecedented demand," "never seen this sort of commitment that far out with better pricing," and "large portion of 2023 revenue already booked.
DAL · Q2 2023 → YESThe question is: Does management convey that the LEVEL OF BUSINESS THE COMPANY IS NOW DOING HAS BECOME ITS NEW NORMAL — that activity which would recently have been exceptional is now the company's cu...YES The transcript shows management framing the current performance as the new baseline: record revenue and earnings, "highest quarterly earnings result in our history," "moves Delta beyond recovery and firmly on a great path forward," and executing ahead of the three-year plan with raised full-year guidance.